Vertex Pharmaceuticals · 2 days ago
Senior Manager, CRM Field Operations Lead
Vertex Pharmaceuticals is in an exciting time of growth and innovation, and they are seeking a Senior Manager, CRM Field Operations Lead. This role is critical in supporting the CRM system for sales and marketing, ensuring customer engagement and alignment with business strategies.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Owns and drives the NA Commercial Sales & Marketing roadmap of annual CRM priorities based on anticipated business needs for designated BUs
Works with IT counterparts to build requirements and manage the agile workflow in JIRA
Responsible for approving & prioritizing development work based on business priorities and user feedback
Proactively identifies and communicates potential new improvements to platforms, leverages subject matter expertise to support both Sales & Marketing in identifying opportunities for improvement and communicating complex technical solutions to business problems
Work closely with DTE to oversee end-to-end sprint management activities and support DTE by addressing business related changes throughout the implementation process
Manages the product backlog, proactively raising issues and constantly conducting prioritization exercises based on changing business requirements within Jira
Provides implementation support including validation of business requirements and User Acceptance Testing (UAT)
Partners with Commercial Training and Change Management teams to ensure necessary supporting materials are provided and training content is consistent with system functionality
Works with Veeva Align team to ensure correct account hierarchy and set up in Align flows into Veeva CRM
Works with Marketing partners on projects that need Veeva CRM integration. Eg: Approved email templates, CLM and training content on iPad, Website - Veeva Integration, Veeva batch emails, etc
Aligns priority decisions with IT business partners, cross-functional teams, business stakeholders & leadership team members
Serves as subject matter expert for the CRM (Veeva) as well as well versed in understanding the varying business processes and supporting technology used amongst the business team
Trains end-users (e.g. field & marketing teams) on utilizing new technology & supports adoption
Qualification
Required
Bachelor's degree in business, technology, or equivalent
7+ years in biopharma technology, with experience supporting Commercial functions and with Veeva CRM/Vault
Deep experience implementing/running technology adoption across global Commercial systems
Experience working with on and offshore vendor partners within an Agile framework
Strong JIRA & Confluence experience
Knowledge of business processes and operations within a Commercial biopharma environment
Exceptional stakeholder management, communication, problem solving, and presentation skills
Strategic mindset; ability to identify process improvement opportunities and then deliver them
Ability to work independently and navigate ambiguity across various levels of an organization
Ability to travel domestically, as needed
Benefits
Annual bonus
Annual equity awards
Overtime pay
Medical, dental and vision benefits
Generous paid time off
Educational assistance programs including student loan repayment
Generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Recent News
MarketScreener
2026-01-03
The Motley Fool
2025-12-30
The Motley Fool
2025-12-28
Company data provided by crunchbase